Infectıon of Hepatıtıs B Vırus and Hepatıtıs C Vırus in Thalassemıa
DOI:
https://doi.org/10.31964/mltj.v11i2.638Keywords:
Antibodies to Hepatitis C Virus, Blood transfusion, Hepatitis B Surface Antigen, Hepatitis B Virus, Hepatitis C VirusAbstract
Thalassemia disease remains incurable and causes many complications. People with thalassemia major require routine lifelong blood transfusions. A main risk of transfusion is infection with diseases transmitted through blood, which is among the most frequent causes of death in thalassemia patients. Transfusion-transmitted infections (TTIs) include hepatitis B and hepatitis C. This study aimed to determine the prevalence of hepatitis B and C in thalassemia patients in Ciamis Regency and examine the relationship between transfusion frequency and these infections. The method was a cross-sectional study on thalassemia patients who received blood transfusions. The study included 191 thalassemia patients at Ciamis Hospital from January to June 2023. Purposive sampling selected 89 patients as the sample. Hepatitis B and C tests used immunochromatography. The prevalence of Hepatitis C Virus and Hepatitis B Virus infections in thalassemia patients in Ciamis Regency was 2.2% and 3.4%, respectively. The chi-square test showed a significant relationship (p < 0.05) between transfusion frequency and hepatitis B and C infection in thalassemia patients. This result suggests a risk of hepatitis B and C infection. Thalassemia patients are potentially susceptible to blood-borne Hepatitis C Virus and Hepatitis B Virus. These infections increase morbidity due to transfusion therapy. Routine inspection for Hepatitis B Virus and Hepatitis C Virus is essential for thalassemia patients. These results emphasize the need for strict screening protocols in blood transfusion processing.References
Ahmed, I., Iqbal, S., & Waheed, A. (2018). Prevalence of Hepatitis B and Hepatitis C in transfusion dependent thalassemia patients. Medical Forum Monthly, 29(9), 76–79.
Akhtar, S., Nasir, J. A., Usman, M., Sarwar, A., Majeed, R., & Billah, B. (2020). The prevalence of hepatitis C virus in hemodialysis patients in Pakistan: A systematic review and meta-analysis. In PLoS. 15(5), 1–13. Public Library of Science. https://doi.org/10.1371/journal.pone.0232931
Al-Sharifi, L. M., Murtadha, J., Shahad, A., Mohammed, Y., Sura, J., Waleed, Z., Raheeq, M., Sura, A., Ehab, H., Shahad, M., & Abbas, Q. (2019). Prevalence of hepatitis B and C in thalassemic patients and its relation with type of thalassemia, frequency of blood transfusion, and spleen status. Medical Journal of Babylon, 16(2), 108–111. https://doi.org/10.4103/MJBL.MJBL_6_19
Astuti, H. P., & Kusumawati, E. (2014). Kajian Efektivitas Pemberian Vaksinasi Hepatitis B Terhadap Pembentukan Antibodi Anti Hbs. Jurnal Kesehatan Kusuma Husada, 4(2), 29–34.
Bhuyan, G. S., Zaman Noor, A. U., Sultana, R., Noor, F. A., Sultana, N., Sarker, S. K., Islam, M. T., Abu Sayeed, M., Ul Khabir, M. I., Ekramul Hossain, A. K. M., Zeba, Z., Qadri, S. K., Furkan Siddique, M. R., Qadri, S. S., Qadri, F., & Mannoor, K. (2021). Frequency of Hepatitis B, C and HIV infections among transfusion-dependent beta thalassemia patients in Dhaka. Infectious Disease Reports, 13(1), 89–95. https://doi.org/10.3390/IDR13010011
Candotti, D., & Allain, J. P. (2013). Molecular virology in transfusion medicine laboratory. In Blood Transfusion.11(2), 203–216. https://doi.org/10.2450/2012.0219-12
Dutta, S., Biswas, A., Bakshi, S., Choudhury, P., Das, R., Nath, S., Chowdhury, P., Bhattacharyya, M., Chakraborty, S., Dutta, S., & Sadhukhan, P. C. (2023). Molecular Epidemiology of HCV Infection among Multi-Transfused β-Thalassemia Patients in Eastern India: A Six-Year Observation. Thalassemia Reports, 13(3), 165–178. https://doi.org/10.3390/thalassrep13030016
Gupta, P., Barnwal, R. K., Sundi, A., & Irfan, S. (2022). burden estimation of hepatitis B & C in thalassemia patients in MGM Medical College and Hospital, Jamshedpur. International Journal of Health Sciences, 6(April), 7360–7366. https://doi.org/10.53730/ijhs.v6ns5.10713
Kandi, V., Vinjamuri, S. R., & Tanikella, B. P. (2021a). Hepatitis C Viral Infection Among Beta-Thalassemia Patients: A Study From the Centre for Excellence in Thalassemia and Other Blood Disorders. Cureus, 13(7), 7–11. https://doi.org/10.7759/cureus.16207
Lee, M. H., Yang, H. I., Yuan, Y., L’Italien, G., & Chen, C. J. (2014). Epidemiology and natural history of hepatitis C virus infection. World Journal of Gastroenterology, 20(28), 9270–9280. https://doi.org/10.3748/wjg.v20.i28.9270
Li, S., Li, J., Xu, Y., Xiang, Z., & Wu, J. (2023). Editorial: Pathogen-host interaction in the development of viral hepatitis. Frontiers in Cellular and Infection Microbiology, 13(November), 1–3. https://doi.org/10.3389/fcimb.2023.1333470
Maffei, L., Sorrentino, F., Caprari, P., Taliani, G., Massimi, S., Risoluti, R., & Materazzi, S. (2020). HCV Infection in Thalassemia Syndromes and Hemoglobinopathies: New Perspectives. Frontiers in Molecular Biosciences, 7(January), 1–6. https://doi.org/10.3389/fmolb.2020.00007
Mandal, T. Kr., Sarkar, S., Haldar, P., Mondal, S., Chatterjee, S. S., Paul, P., Ray, R., Ghosh, R. R., Saha, S., & Dan, U. (2024). Prevalence of HIV, hepatitis B and hepatitis C infections among patients with thalassemia attending a tertiary care (rural) hospital. Journal of Family Medicine and Primary Care, 13(5), 1780–1786. https://doi.org/10.4103/jfmpc.jfmpc_1751_23
Mansour, A. K., Aly, R. M., Abdelrazek, S. Y., Elghannam, D. M., Abdelaziz, S. M., Shahine, D. A., Elmenshawy, N. M., & Darwish, A. M. (2012). Prevalence of HBV and HCV infection among multi-transfused Egyptian thalassemic patients. Hematology/ Oncology and Stem Cell Therapy, 5(1), 54–59. https://doi.org/10.5144/1658-3876.2012.54
Mirzaei, G., Shamsasenjan, K., Jafari, B., Bagherizadeh, Y., Sadafzadeh, A., Bannazadeh-Baghi, H., Sadeghi-Deylamdeh, Z., & Jafari-Sales, A. (2021). Prevalence of HBV and HCV infection in beta-thalassemia major patients of Tabriz city, Iran. New Microbes and New Infections, 43, 100912. https://doi.org/10.1016/j.nmni.2021.100912
Moghimbeygi, M., & Alavian, S. M. (2020). Eradication of hepatitis C virus infection in thalassemia patients in Iran using various treatment strategies. Journal of Virus Eradication, 6(3), 1–6. https://doi.org/10.1016/J.JVE.2020.100006
Mohammed Hasan, K., Ahmad Rashid, J., & Khasraw Ghafoor, I. (2020). Prevalence of Hepatitis C Virus Infection Among Children With Beta Thalassemia Major in Sulaimani. Journal of Sulaimani Medical College, 10(1), 89–96. https://doi.org/10.17656/jsmc.10244
Moonsamy, S., Suchard, M., Pillay, P., & Prabdial-Sing, N. (2022). Prevalence and incidence rates of laboratory-confirmed hepatitis B infection in South Africa, 2015 to 2019. BMC Public Health, 22(1), 1–13. https://doi.org/10.1186/s12889-021-12391-3
Naidu, N. K., Bharucha, Z. S., Sonawane, V., & Ahmed, I. (2016). Nucleic acid testing: Is it the only answer for safe Blood in India. Asian Journal of Transfusion Science, 10(1), 79–83. https://doi.org/10.4103/0973-6247.175423
Naz, R., Ullah, F., Muhammad, T., Khan, O., Shah, F., Rehman, A. u, & Basir, N. U. (2023). Incidence of Hepatitis B Due to Multiple Transfusions in Patients of β-Thalassemia Major. Pakistan Journal of Health Sciences, 4(2 February 2023), 86–90. https://doi.org/10.54393/pjhs.v4i02.558
Origa, R. (2023). Hepatitis C and Thalassemia: A Story with (Almost) a Happy Ending. Pathogens, 12(5), 1–15. https://doi.org/10.3390/pathogens12050683
Pius, O., Ekundayo, O., & Abiodun, S. (2022). Sero-Prevalence of Transfusion Transmissible Hepatitis Viruses Among Blood Donors in Ilorin, Kwara State. International Journal of Applied Biology, 6(2),14–35.
Rakhmina, D., Norsiah, W., Herlina, T. E., Sari, N. M., Pertiwi, R., Ariani, R., & Rahman, S. (2021). Immune Response to anti-HBs Antibodies in Health Workers Following Hepatitis B Vaccination. Medical Laboratory Technology Journal, 7(2), 182–193. https://doi.org/10.31964/mltj.v7i2.418
Riaz, M., Abbas, M., Rasool, G., Baig, I. S., Mahmood, Z., Munir, N., Mahmood Tahir, I., Ali Shah, S. M., & Akram, M. (2022). Prevalence of transfusion-transmitted infections in multiple blood transfusion-dependent thalassemic patients in Asia: A systemic review. International Journal of Immunopathology and Pharmacology, 36, 1–9. https://doi.org/10.1177/03946320221096909
Trompeter, S. , and M. A. (2021). Blood transfusion. In F. D. P. J. Cappellini MD (Ed.), Guidelines: For the Management of Transfusion Dependent Thalassaemia (TDT) (4th ed.). Thalassaemia International Federation.
Shenge, J. A., & Osiowy, C. (2021). Rapid Diagnostics for Hepatitis B and C Viruses in Low- and Middle-Income Countries. In Frontiers in Virology (Vol. 1, Issue October, pp. 1–12). Frontiers Media SA. https://doi.org/10.3389/ fviro.2021.742722
Waheed, U., Saba, N., Wazeer, A., & Ahmed, S. (2021). A Systematic Review and Meta-Analysis on the Epidemiology of Hepatitis B and Hepatitis C Virus among Beta-Thalassemia Major Patients in Pakistan. Journal of Laboratory Physicians, 13(03), 270–276. https://doi.org/10.1055/s-0041-1731110
WHO. (2021b, September 7). Regional desk review of haemoglobinopathies with an emphasis on thalassaemia and accessibility and availability of safe blood and blood products as per these patients’ requirement in South-East Asia under universal health coverage. Https://Www.Who.Int/Publications/i/Item/ 9789290228516.
WHO. (2025, May 30). Blood safety and availability. Https://Www.Who.Int/News-Room/Fact-Sheets/Detail/Blood-Safety-and-Availability?
Yousuf, R., Akter, S., Wasek, S. M., Sinha, S., Ahmad, R., & Haque, M. (2022). Thalassemia: A Review of the Challenges to the Families and Caregivers. Cureus, 14(12), 8–15. https://doi.org/10.7759/cureus.32491.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Doni Setiawan, Euis Tia Istianah, Dini Ariani, Henri Setiawan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Publishing your paper with Medical Laboratory Technology Journal (MLTJ) means that the author or authors retain the copyright in the paper. MLTJ granted an author(s) rights to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by MLTJ in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage.
MLTJ journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially. MLTJ journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:
BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.SA: If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
